Compositions comprising cinnamaldehyde and zinc and methods of using such compositions

US11110120B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11110120-B2
Application numberUS-201615573562-A
CountryUS
Kind codeB2
Filing dateMay 24, 2016
Priority dateJun 5, 2015
Publication dateSep 7, 2021
Grant dateSep 7, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The cinnamaldehyde is supplemented by zinc, and the combination can be effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. The composition can improve one or more of insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood or memory. The composition can achieve a therapeutic effect selected from the group consisting of blood vessel dilation, reduced blood pressure, increased delivery of blood flow to tissues in the body, stimulation of protein synthesis, increased release of growth factors, enhanced immune function, and combinations thereof.

First claim

Opening claim text (preview).

The invention is claimed as follows: 1. A method for treating or reducing a risk and/or a severity of high blood pressure, the method comprising administering a food product to a human in need thereof and who is not obese or overweight, the food product comprising cinnamaldehyde and zinc in a cinnamaldehyde:zinc ratio in molarity of 1:0.5 to 1:0.005, the food product is selected from the group consisting of a beverage, a cereal bar, a dairy bar, a soup, a breakfast cereal, muesli, a candy, a cookie, a biscuit, a cracker, a dairy product, a tablet, a capsule, a pastille and a liquid, the food product comprising the cinnamaldehyde at a flavoring concentration of from 31.87 ppm to 6191 ppm, and the food product comprises at least one of zinc chloride, zinc sulfate, zinc lactate or zinc citrate that provides at least a portion of the zinc. 2. The method of claim 1 , wherein the food product is administered to the human at least once a day for at least one week. 3. The method of claim 1 , wherein the cinnamaldehyde:zinc ratio in molarity is 1:0.03. 4. The method of claim 1 , wherein at least a portion of the cinnamaldehyde is at least one of isolated cinnamaldehyde or chemically synthesized cinnamaldehyde. 5. The method of claim 1 , wherein the cinnamaldehyde:zinc ratio in molarity is about 1:0.03.

Assignees

Inventors

Classifications

  • Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title

  • Aldehydes · CPC title

  • Inorganic salts, minerals or trace elements · CPC title

  • Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title

  • A61K33/30Primary

    Zinc; Compounds thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11110120B2 cover?
Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The cinnamaldehyde is supplemented by zinc, and the combination can be effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation. The composition comprising the combination o…
Who is the assignee on this patent?
Nestec Sa, Nestle Sa
What technology area does this patent fall under?
Primary CPC classification A61K33/30. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).